Informing evidence-based clinical practice guidelines for children with cerebral palsy at risk of osteoporosis: an update

Pamidronate Treatment to Prevent Reoccurring Fractures in Children With Cerebral Palsy

(2016) Julieanne P. Sees et al.   JOURNAL OF PEDIATRIC ORTHOPAEDICS

The Use of Bisphosphonates in Pediatrics

(2014) Giampiero I. Baroncelli et al.   Hormone Research in Paediatrics

Intravenous Zoledronic Acid Given Every 6 Months in Childhood Osteoporosis

(2013) Hooi Leng Ooi et al.   Hormone Research in Paediatrics

Efficacy of home-based virtual cycling training on bone mineral density in ambulatory children with cerebral palsy

(2012) C.-L. Chen et al.   OSTEOPOROSIS INTERNATIONAL

Osteopenia in children with cerebral palsy can be treated with oral alendronate

(2011) Muhammet Sukru Paksu et al.   CHILDS NERVOUS SYSTEM

Long-term outcomes of children and adolescents who had cerebral palsy with secondary osteoporosis

(2011) Toshiyuki Iwasaki et al.   CURRENT MEDICAL RESEARCH AND OPINION

Informing evidence-based clinical practice guidelines for children with cerebral palsy at risk of osteoporosis: a systematic review

(2011) DARCY FEHLINGS et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Alendronate for the Treatment of Pediatric Osteogenesis Imperfecta: A Randomized Placebo-Controlled Study

(2010) L. M. Ward et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pamidronate improves pain, wellbeing, fracture rate and bone density in 14 children and adolescents with chronic neurological conditions

(2010) Warwick Howe et al.   Developmental Neurorehabilitation